1. redoctober30
2. hawktalkin
3. chulwus
4. danvettraino49
5. pierceton
1.chulwus 04/30/2018
AbbVie Presents New Investigational Data for Elagolix at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting
2.hawktalkin 02/14/2018
Announced that the FDA
3.hawktalkin 02/13/2018
Reports Q4 earnings of $0.07 per share.
4.redoctober30 02/13/2018
ER
5.redoctober30 04/25/2018
Neurocrine Biosciences Presents New Data Analyses at AAN Annual Meeting Demonstrating INGREZZA® Improved Tardive Dyskinesia Symptoms Across Body Regions
6.redoctober30 01/08/2018
Most recent news: - Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2017 Sales Results and 2018 Program Milestones
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW